This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Technical debt (tech debt), referring to the deferred maintenance and upgrades of a system, is commonly accrued in the healthcare and lifesciences industries. Another factor in determining the worth of addressing vulnerabilities is the fact that consumers and patients have little tolerance for cybersecurity lapses.
It’s new approaches and ideas like these that will build a skilled workforce that is ready to protect the healthcare delivery system from existing and future cybersecurity threats. Here I agree – we can use all the help we can get.
By training staff effectively and adopting these safeguards, healthcare organizations can significantly reduce the risk of vulnerabilities and enhance their overall security posture. To increase transparency, leadership teams should map out production sites, distribution centers, and material flows against potential hazards.
The following is a guest article by Justin Kozak, LifeSciences Specialist at Founder Shield In an era where digital innovation drives healthcare forward, healthtech companies are at the forefront of a double-edged sword.
At the conference, we’ve been asking some of the top companies, executives, and health IT leaders to share some of their perspectives and insights on a wide variety of topics including AI, Security, workforce, leadership and more. Plus, we’re asking health IT vendors what announcements they are making at the event.
These technologies also reduce the burden on the stretched security resources in healthcare organizations, freeing up IT personnel to focus on other important tasks in their organizations.
The following is a guest article by Zack Tisch, Senior Vice President of Innovation and LifeSciences at Pivot Point Consulting Medical devices have long existed and added value at points in the healthcare experience.
These comprehensive strategies are essential for strengthening the cybersecurity posture of healthcare organizations and protecting sensitive information. Pratik Maroo, Head of Healthcare and LifeSciences at Zensar The first step is to assess its vulnerabilities and strengths.
As the industry continues to evolve, these proactive measures not only mitigate risks but also contribute to overall healthcare cyber resilience, ensuring the safety of patient data and the continuity of exceptional care delivery.
Currently, Steve is responsible for the North American Healthcare and LifeSciences Vertical as well as the Central Region for Ping Identity serving as their Vice President.
Pratik Maroo, Head of Healthcare and LifeSciences at Zensar It is estimated that the value of medical IoT devices will be $467.25 billion by 2027. The pandemic accelerated the adoption of emerging regulations to expedite the use of IoT in the medical world.
Verma also highlighted to me how Oracle’s lifesciences relationships can be leveraged as well. There’s a lot of potential there, but a lot of questions as well.
The use of public generative AI (GenAI) will take longer to enter the space due to the risk of leaked intellectual property, which is critical in lifesciences, however, as private GPT becomes possible use of GPT will increase. As these trends increase, there will be an expansion of investment in predictive and preventative analytics.
Though it may be too early to expect any form of regulation this year regarding AI from governing bodies in lifesciences, we all know it is coming. Increasingly, lifescience organizations are turning toward automation for their regulatory processes, but the industry will not be fully reliant on automated processes in the coming year.
Patty Hayward, General Manager of Healthcare and LifeSciences at Talkdesk Provider organizations in 2024 will be motivated to leverage Artificial Intelligence (AI) and Generative AI to improve the customer experience for patients.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content